Minister for Finance Paschal Donohoe has rejected claims from the Irish Fiscal Advisory Council that his spending forecasts “lack credibility”.

The Minister for Finance Paschal Donohoe has rejected claims from the Irish Fiscal Advisory Council that his spending forecasts “lack credibility” and(...)

President and CEO of Takeda Christophe Weber  at the official opening of Takeda Ireland’s new cutting-edge manufacturing facility at its Grange Castle site in Dublin. Photograph:   Jason Clarke

Christophe Weber is not afraid of bold moves. He was the first foreigner to lead Japan’s top pharmaceutical company, Takeda, when he was appointed in (...)

Takeda   has invested €40 million at Grange Castle to build a new plant . Photograph: Arnd Wiegmann/Reuters

Investing in specialist waste management facilities would strengthen Ireland’s hand in attracting more foreign investment, a global pharmaceuticals ch(...)

Takeda chief executive Christophe Weber with Mary Buckley, IDA Ireland executive dIrector (centre),  and Minister for Employment Affairs Regina Doherty at the official opening of Takeda Ireland’s new cancer drug manufacturing facility at Grange Castle in Dublin.  Photograph: Jason Clarke.

Japanese pharma group Takeda opened a new state-of-the-art cancer drug manufacturing plant in Dublin on Friday. The €40 million plant will be used to(...)

Shareholders of Takeda Pharmaceutical arriving for a  shareholders’ meeting in Osaka, Japan, on December 5th. Photograph: Kyodo/via Reuters

Takeda Pharmaceutical has won key shareholder approval to finance its £46 billion (€51.6bn) takeover of Shire, paving the way for Japan’s largest corp(...)

Any sale of Shire assets would only take place after Takeda’s takeover of the drugmaker is completed. Photograph: Simon Dawson/Bloomberg

Takeda Pharmaceuticals is weighing the sale of a Shire eye care business once its $62 billion (€53.36 billion) purchase of the Irish-headquartered bio(...)

Shire investors will receive $30.33 in cash and either 0.839 new Takeda shares or 1.678 Takeda ADSs for each share. Photograph: Clodagh Kilcoyne/Reuters

Takeda Pharma agreed to buy Ireland-headquartered Shire for £45.3 billion (€51.6 billion) on Tuesday after the Japanese company raised the amount of (...)

Shares in Takeda tumbled further on Wednesday on news of the Shire deal. Photograph: Suzanne Plunkett/Reuters

Rare disease drug maker Shire said on Tuesday it was willing to recommend a sweetened $64 billion offer from Japan’s Takeda to shareholders, in what (...)

Shire’s board “is considering its position” on a new bid from Takeda.

Dublin-based pharma giant Shire is considering a new offer from Takeda Pharmaceutical after the Japanese drugmaker revised its roughly $60 billion (€4(...)

Takeda is not considering purchasing only some businesses or assets, Credit Suisse said in a note. Photograph: Kim Kyung-Hoon/Reuters

Takeda Pharmaceutical chief executive Christophe Weber is contemplating a deal for all of Shire, telling a select audience that size is not an obstacl(...)

  • 1
  • 2
  • Next
  • Last »